title: Generation and characterization of a mouse model of the metabolic syndrome: apolipoprotein E and aromatase double knockout mice.
abstract: The aim of this study was to create a comprehensive mouse model of the metabolic syndrome by crossing aromatase-deficient (ArKO) mice with apolipoprotein E-deficient (ApoE(-/-)) mice. Successive crossbreeding of ArKO with ApoE(-/-)-deficient mice generated double knockout, MetS-Tg mice. The phenotypic characteristics of the MetS-Tg mice were assessed at 3, 6, and 12 mo of age and compared with age- and sex-matched wild-type (WT) controls. Blood pressure and heart rate were recorded by a noninvasive, computerized tail-cuff system. Oral glucose and intraperitoneal insulin tolerance tests were performed. Serum cholesterol levels were measured by a combined quantitative colorimetric assay. Plasma adiponectin, C-reactive protein (CRP), insulin, interleukin-6 (IL-6), leptin, resistin, and tumor necrosis factor-α (TNF-α) were measured by multiplexed ELISA. MetS-Tg mice displayed significantly increased body weight, central obesity, and elevated blood pressure at all three ages compared with WT mice. Elevated serum cholesterol was associated with higher triglycerides and LDL/VLDL cholesterol particles and was accompanied by a decrease in HDL and histological evidence of fatty liver. MetS-Tg mice of all ages showed impaired glucose tolerance. At 12 mo, MetS-Tg mice had elevated plasma levels of CRP, IL-6, leptin, and TNF-α, but resistin levels were largely unchanged. We now report that this combination of gene knockouts produces a novel strain of mice that display the diverse clinical features of the metabolic syndrome, including central obesity, progressive hypertension, an adverse serum lipid profile, fatty liver, glucose intolerance, insulin resistance, and evidence of an inflammatory state.
authors.affiliation: Dept. of Medicine, Univ. of Otago-Christchurch, Christchurch, NZ. nicola.scott@otago.ac.nz
authors.forename: Nicola J A
authors.initials: NJ
authors.lastname: Scott
authors.forename: Vicky A
authors.initials: VA
authors.lastname: Cameron
authors.forename: Sara
authors.initials: S
authors.lastname: Raudsepp
authors.forename: Lynley K
authors.initials: LK
authors.lastname: Lewis
authors.forename: Evan R
authors.initials: ER
authors.lastname: Simpson
authors.forename: A Mark
authors.initials: AM
authors.lastname: Richards
authors.forename: Leigh J
authors.initials: LJ
authors.lastname: Ellmers
mesh_terms: D052436:Adipose Tissue, White / Q000276:immunology / Q000473:pathology; D000818:Animals; D001011:Aorta / Q000276:immunology / Q000473:pathology; D001057:Apolipoproteins E / Q000235:genetics / Q000502:physiology*; D001141:Aromatase / Q000235:genetics / Q000502:physiology*; D050197:Atherosclerosis / Q000209:etiology; D002097:C-Reactive Protein / Q000032:analysis; D003433:Crosses, Genetic; D016207:Cytokines / Q000097:blood; D004195:Disease Models, Animal; D005234:Fatty Liver / Q000209:etiology; D005260:Female; D018149:Glucose Intolerance / Q000209:etiology; D006949:Hyperlipidemias / Q000209:etiology; D006973:Hypertension / Q000209:etiology; D007333:Insulin Resistance; D008099:Liver / Q000276:immunology / Q000473:pathology; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood / Q000276:immunology / Q000473:pathology / Q000503:physiopathology*; D051379:Mice; D018345:Mice, Knockout; D056128:Obesity, Abdominal / Q000209:etiology
chemical_list: D001057:Apolipoproteins E; D016207:Cytokines; D002097:C-Reactive Protein; D001141:Aromatase